RBC Capital lowered the firm’s price target on Legend Biotech (LEGN) to $84 from $86 and keeps an Outperform rating on the shares as part of a ...

Analyst Kostas Biliouris from BMO Capital reiterated a Buy rating on Legend Biotech (LEGN – Research Report) and keeping the price target at ...

The John Deere leaping-deer logo and green and yellow colors are as familiar as the phrase "Nothing runs like a Deere." But ...